Jean Claude Guillemot
About Jean Claude Guillemot
Jean Claude Guillemot serves as the Directeur Adjoint at Aix-Marseille Université, where he has worked since 1999. He specializes in antiviral drug design, focusing on emerging viruses and leads the Antiviral Drug Design Platform, integrating research with antiviral development.
Work at Aix-Marseille University
Jean Claude Guillemot has served as Directeur Adjoint at Aix-Marseille Université since 1999. In this role, he has contributed to the university's research initiatives and academic programs. His leadership within the institution spans over 25 years, during which he has been involved in various projects related to antiviral drug design and development.
Education and Expertise
Jean Claude Guillemot holds multiple advanced degrees. He earned his PhD in Biology from Université Paul Sabatier Toulouse III, studying from 1991 to 1995. He furthered his education at Harvard Medical School, where he completed another PhD in 1995. Additionally, he obtained an MBA Executive from Aix-Marseille Graduate School of Management - IAE, studying from 2014 to 2016. His educational background supports his expertise in antiviral drug design.
Research Focus and Contributions
Guillemot focuses on antiviral drug design, particularly concerning emerging viruses such as Flavivirus, Coronavirus, and Filovirus. He leads the Antiviral Drug Design Platform (AD2P), which aims to integrate basic research with the practical development of antiviral medications. His work is crucial in addressing the challenges posed by these viruses.
Background
Jean Claude Guillemot has a strong academic and professional background in biology and management. His studies at prestigious institutions have equipped him with a solid foundation in both scientific research and organizational leadership. His career reflects a commitment to advancing knowledge in the field of virology and drug development.